Literature DB >> 10736939

[Evaluation and validation of Omron Hem 705 CP and Hem 706/711 monitors for self-measurement of blood pressure].

L M Artigao1, J J Llavador, A Puras, J López Abril, M M Rubio, C Torres, A Vidal, C Sanchis, J A Divisón, F Naharro, D Caldevilla, G Fuentes.   

Abstract

OBJECTIVE: To validate two devices for self-measurement of blood pressure--The Omron Hem-705CP and the Omron Hem 706/711--according to the revised protocol of the British Hypertension Society (BHS). The results were also analysed according to the criteria for accuracy of the revised standard of the Association for the Advancement of Medical Instrumentation (AAMI).
DESIGN: The British Hypertension protocol for the evaluation of blood pressure measuring devices.
SETTING: Primare care. Zone III Health Care in Albacete (Spain). PARTICIPANTS: 95 subjects to validate the Omron 706/711 and 100 subjets to Omron 705.
RESULTS: Two monitors surpassed the validation according to the standars set out by the BHS protocol (705 with a A grading for SBP and DBP, 706/711 obtained a B grading for SBP and an A grading for DBP and a PASS for SBP and DBP. Upon analyzing the behavior of the appliances by subgroups of BP measures (high, mid, and low), 705 for SBP > 160 mmHg obtained a B grading for the BHS protocol, but it did not pass the accuracy AAMI criteria (SD, 8.5, but difference between observers-device is -0.1 mmHg). The rest of subgroups of BP obtained a A grading for the BHS protocol and a PASS (AAMI). 706/711 surpassed in all BP subgroups BHS protocol, for DBP 80-100, SBP > 160 and DBP > 100 with a B grading, for the rest of BP subgroups obtained a B grading and a PASS (AAMI).
CONCLUSIONS: On the basis of these results, we conclude both monitors Omron HEM 706/711 and the Omron 705CP surpassed the accuracy criteria required for BHS and AAMI, and can be recommended for clinical use.

Entities:  

Mesh:

Year:  2000        PMID: 10736939     DOI: 10.1016/s0212-6567(00)78470-8

Source DB:  PubMed          Journal:  Aten Primaria        ISSN: 0212-6567            Impact factor:   1.137


  9 in total

1.  Effect of statin therapy on disease progression in pediatric ADPKD: design and baseline characteristics of participants.

Authors:  Melissa A Cadnapaphornchai; Diana M George; Amirali Masoumi; Kim McFann; John D Strain; Robert W Schrier
Journal:  Contemp Clin Trials       Date:  2011-01-23       Impact factor: 2.226

2.  [Accuracy and precision in blood pressure measurement. Comparative study of home self-measurement with measurement in the clinic and out-patient monitoring].

Authors:  J Divisón; A Puras; C Sanchis; L Artigao; J López Abril; E López De Coca; J Massó; B Rodríguez Paños
Journal:  Aten Primaria       Date:  2001-03-31       Impact factor: 1.137

3.  Effect of pravastatin on total kidney volume, left ventricular mass index, and microalbuminuria in pediatric autosomal dominant polycystic kidney disease.

Authors:  Melissa A Cadnapaphornchai; Diana M George; Kim McFann; Wei Wang; Berenice Gitomer; John D Strain; Robert W Schrier
Journal:  Clin J Am Soc Nephrol       Date:  2014-04-10       Impact factor: 8.237

4.  The effect of numeracy level on completeness of home blood pressure monitoring.

Authors:  Vishal N Rao; Stacey L Sheridan; Laura A Tuttle; Feng-Chang Lin; Daichi Shimbo; Keith M Diaz; Alan L Hinderliter; Anthony J Viera
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-11-29       Impact factor: 3.738

5.  Effects of a 6-Month Walking Study on Blood Pressure and Cardiorespiratory Fitness in U.S. and Swedish Adults: ASUKI Step Study.

Authors:  Ali Soroush; Cheryl Der Ananian; Barbara E Ainsworth; Michael Belyea; Eric Poortvliet; Pamela D Swan; Jenelle Walker; Agneta Yngve
Journal:  Asian J Sports Med       Date:  2013-02-10

6.  Determinants of the Morning-Evening Home Blood Pressure Difference in Treated Hypertensives: The HIBA-Home Study.

Authors:  Lucas S Aparicio; Jessica Barochiner; Paula E Cuffaro; José Alfie; Marcelo A Rada; Margarita S Morales; Carlos R Galarza; Marcos J Marín; Gabriel D Waisman
Journal:  Int J Hypertens       Date:  2014-12-14       Impact factor: 2.420

7.  Prognostic value of home blood pressure monitoring in patients under antihypertensive treatment.

Authors:  Jessica Barochiner; Lucas S Aparicio; Rocío Martínez; José Boggia
Journal:  J Hum Hypertens       Date:  2022-09-26       Impact factor: 2.877

8.  Predictors of short- and long-term adherence with a Mediterranean-type diet intervention: the PREDIMED randomized trial.

Authors:  Mary Kathryn Downer; Alfredo Gea; Meir Stampfer; Ana Sánchez-Tainta; Dolores Corella; Jordi Salas-Salvadó; Emilio Ros; Ramón Estruch; Montserrat Fitó; Enrique Gómez-Gracia; Fernando Arós; Miquel Fiol; Francisco Jose Garcia De-la-Corte; Lluís Serra-Majem; Xavier Pinto; Josep Basora; José V Sorlí; Ernest Vinyoles; Itziar Zazpe; Miguel-Ángel Martínez-González
Journal:  Int J Behav Nutr Phys Act       Date:  2016-06-14       Impact factor: 6.457

9.  Arterial Stiffness in Treated Hypertensive Patients With White-Coat Hypertension.

Authors:  Jessica Barochiner; Lucas S Aparicio; José Alfie; Margarita S Morales; Paula E Cuffaro; Marcelo A Rada; Marcos J Marin; Carlos R Galarza; Gabriel D Waisman
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-09-28       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.